Abstract:Abstract Disclosure: J. Ambalavanan: None. O. Abdulhussein: None. J. Ferri-Guerra: None. G. Madrigal Loria: None. K. Alkwatli: None. A. Iqbal: None. R.R. Correa: None. Introduction: Maturity-Onset Diabetes of the Young (MODY) is a rare monogenic form of diabetes characterized by impaired beta cell function accounting for < 5% of all people with diabetes. About 14 different subtypes of MODY have been described in the. MODY 10 is an extremely rare form with mutation in the INS (insulin) gene. We present a previously unreported genetic mutation in the INS gene, its clinical course and subsequent management. Case: A 23-year-old female presented to us for consultation regarding new diagnosis of diabetes. She came to medical attention for pre-diabetes at the age of 16 years and was managed with diet control. She was officially diagnosed with diabetes by PCP in October 2022 after onset of polyuria and nocturia, and HbA1c of 8.7%. During initial evaluation, we suspected type 1 diabetes due to her age, low BMI of 17.61 kg/m2 and prescribed a CGM while we awaited extensive antibody evaluation. Within a week she reported average blood sugars in the 200-300 mg/dl range. As a result, she was on insulin glargine 5 units at bedtime. Within 3 months, her HbA1c dropped to 6.5% but she started experiencing frequent symptomatic hypoglycemia at work. At this point we suspected MODY due to age at diagnosis; antibody negative status for GAD-65, IA-2, ZnT8 and insulin; detectable C-peptide 1.7 ng/ml (0.81-3.85); low BMI and good glycemic control and frequent hypoglycemia on insulin. On evaluation of family history, she had a history of diabetes in maternal grandmother, paternal grandfather and paternal great uncle. Her parents did not have diabetes. We stopped glargine and started glipizide XL 2.5mg once daily. She was also referred to our clinical genetics team. On genetic evaluation she was found to have one heterozygous variant of uncertain significance in the INS gene. On further evaluation, this was found to be guanine to adenine substitution at c:139 in exon 2 of the INS gene on chromosome 11:2182063 resulting in a variant protein p.Gly47Ser which is a missense change that occurs when glycine (Gly) is replaced by serine (Ser) at position 47. This mutation has not been previously reported to be pathogenic or benign and has not been reported in significant frequency anywhere based on our literature search. Furthermore, in silico analysis supported that this missense variant had a deleterious effect on the insulin structure/function. Given the rarity of this condition, there are no formal guidelines or consensus regarding the management. During a subsequent follow up visit, we discussed that she fit the diagnosis clinically and suggested possible medications. In the end, we decided to change her from glipizide to sitagliptin 50mg daily as she was continuing to have lows at work. This helped avoid hypoglycemia and maintained time in rage at 98%. Conclusion: We present a patient with rare form of MODY 10 with a new mutation in c139:G>A at exon 2 of INS gene managed with sulfonylurea and eventually DPP4 inhibitor. Presentation: 6/2/2024

Whole-exome Sequencing Identifies a Novel INS Mutation Causative of Maturity-Onset Diabetes of the Young 10.

Identification of Ala2Thr Mutation in Insulin Gene from a Chinese MODY10 Family.

A Missense Mutation in IRS1 is Associated with the Development of Early-Onset Type 2 Diabetes

Progress of Diagnosis and Treatment for Maturity-Onset Diabetes of the Young

Clinical and Functional Characterization of a Novel KCNJ11 (c.101g > A, P.r34h) Mutation Associated with Maturity-Onset Diabetes Mellitus of the Young Type 13

A novel mutation in INS gene linked to permanent neonatal diabetes mellitus

Identification of Maturity-Onset Diabetes of the Young Caused by Mutation in FOXM1 via Whole-Exome Sequencing in Northern China

A Novel C.125 T>G (p.val42gly) Mutation in the Human INS Gene Leads to Neonatal Diabetes Mellitus Via a Decrease in Insulin Synthesis.

6429 An Unusual Gene Mutation and Clinical Manifestation of MODY 10

Recognition of Maturity‐onset Diabetes of the Young in China

Screening and Functional Analysis of Mutations in NEUROD1 Gene in Pedigrees of Maturity-Onset Diabetes of the Young

The first E59Q mutation identified in the NEUROD1 gene in a Chinese family with maturity-onset diabetes of the young: an observational study

A novel nonsense mutation c.747C>G in the NEUROD1 gene detected within a Chinese family affected by maturity‐onset diabetes of the young type 6

Studies of Genetic Variability of the Hepatocyte Nuclear Factor-1Α Gene in an Indian Maturity-Onset Diabetes of the Young Family.

Functional Characterization of a Novel Heterozygous Mutation in the Glucokinase Gene That Causes MODY2 in Chinese Pedigrees

Unraveling the genetic basis of MODY: insights from next-generation sequencing

1466-P: Screening and Functional Analysis of Mutations and Variations in NEUROD1 Gene in Pedigrees of Maturity-Onset Diabetes of the Young

Experimental Models Of Transcription Factor-Associated Maturity-Onset Diabetes Of The Young

ABCC8-related maturity-onset diabetes of the young: Clinical features and genetic analysis of one case

A Novel Mutation, Ser159Pro in the NeuroD1/BETA2 Gene Contributes to the Development of Diabetes in a Chinese Potential MODY Family

P-21 Maturity onset diabetes of the young 7: Case report